BioDelivery Sciences International, Inc. (BDSI): How It Stacks Up Against Its Peers

Seeing as BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has experienced declining sentiment from the entirety of the hedge funds we track, it’s easy to see that there lies a certain “tier” of money managers who were dropping their positions entirely heading into Q4. At the top of the heap, Steven Boyd’s Armistice Capital cashed in the largest stake of all the hedgies followed by Insider Monkey, valued at about $6.3 million in stock, and Benjamin A. Smith’s Laurion Capital Management was right behind this move, as the fund said goodbye to about $0.3 million worth of shares.

Let’s now take a look at hedge fund activity in other stocks similar to BioDelivery Sciences International, Inc. (NASDAQ:BDSI). We will take a look at Xunlei Ltd (NASDAQ:XNET), KVH Industries, Inc. (NASDAQ:KVHI), Genocea Biosciences Inc (NASDAQ:GNCA), and Genie Energy Ltd (NYSE:GNE). This group of stocks’ market valuations are closest to BDSI’s market valuation.

As you can see these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $9 million. That figure was $35 million in BDSI’s case. Xunlei Ltd (NASDAQ:XNET) is the most popular stock in this table. On the other hand Genie Energy Ltd (NYSE:GNE) is the least popular one with only 5 bullish hedge fund positions. Compared to these stocks BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers and are more overweight the stock, it may be a good idea to analyze it in detail and potentially include it in your portfolio. However, the continued decline in ownership is cause for concern.

Disclosure: None